Trials Sponsors Conditions Drugs Pricing

Conditions

Fulminating Hepatic Failure

Outcome Measures

Primary Outcomes (1)

The main objective is to determine the medical fate (transplanted or not and living or deceased), of patients with Severe and fulminating acute hepatic failure within AP-HP hospitals
Patient status 1 month after diagnosis of this episode (alive or dead with or without transplantation)
1 month from the diagnosis of this episode

Secondary Outcomes (4)

Epidemiology of Severe and fulminating acute hepatic failure
Baseline
Cause of death
From date of inclusion until the date of death from any cause, assessed up to 9 years
Analysis of Clinical Pathway
up to 1month after the diagnosis of this episode
Reasons for new hospitalizations with an admission date within 6 months after the diagnosis this episode
within 6 months after the diagnosis this episode

Study Arms (1)

all patients diagnosed with a severe hepatic failure

Retrospective cohort using only data already entered in the Health data warehouse of the APHP (Public Paris Hospital)

Eligibility Criteria

Age15 Years+

Sexall

Healthy VolunteersNo

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Patient with Severe liver failure or toxicants that may cause a liver failure

You may qualify if:

Age \> 15

Sponsors & Collaborators

Assistance Publique - Hôpitaux de Paris
Otherlead

Study Sites (1)

Paul Brousse Hospital

Villejuif, 94804, France

Philippe ICHAI, MD, PhDCONTACT+33 (1) 45 59 64 35 philippe.ichai@aphp.fr

Philippe ICAHI, MD, PhDPRINCIPAL INVESTIGATOR

MeSH Terms

Conditions

Liver Failure, Acute

Condition Hierarchy (Ancestors)

Liver FailureHepatic InsufficiencyLiver DiseasesDigestive System Diseases

Central Study Contacts

Philippe ICHAI

CONTACT

01 45 59 64 35 philippe.ichai@aphp.fr

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: RETROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

September 21, 2020

First Posted

December 8, 2020

Study Start

April 1, 2021

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Primary Completion

December 1, 2021

Estimated (date passed)

Patients' Outcome With Severe or Fulminant Hepatic Insufficiency, Hospitalized in the Public Hospitals of Paris

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (4)

Study Arms (1)

all patients diagnosed with a severe hepatic failure

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (4)

Study Arms (1)

all patients diagnosed with a severe hepatic failure

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations